Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations | Zendy

Gabriel J. Escobar | Zendy; Tebeb Gebretsadik | Zendy; Kecia N. Carroll | Zendy; Shengxi Li | Zendy; Erica M. Walsh | Zendy; Pingsheng Wu | Zendy; Edward F. Mitchel | Zendy; Chantel Sloan | Zendy; Tina V. Hartert | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adherence to Immunoprophylaxis Regimens for Respiratory Syncytial Virus Infection in Insured and Medicaid Populations

Author(s) -

Gabriel J. Escobar,

Tebeb Gebretsadik,

Kecia N. Carroll,

Shengxi Li,

Erica M. Walsh,

Pingsheng Wu,

Edward F. Mitchel,

Chantel Sloan,

Tina V. Hartert

Publication year - 2013

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/pit007

Subject(s) - medicine , medicaid , pediatrics , odds ratio , cohort , guideline , health care , pathology , economics , economic growth

Immunoprophylaxis is the only pharmaceutical intervention for mitigating respiratory syncytial virus (RSV) infection. Patient level data on adherence to American Academy of Pediatrics (AAP) immunoprophylaxis recommendations are limited. This study characterizes adherence to AAP guidelines in privately insured and Medicaid populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research